Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Oct 14, 2022
Date Accepted: Apr 19, 2023
Date Submitted to PubMed: Aug 26, 2023

The final, peer-reviewed published version of this preprint can be found here:

Store-and-Forward Teledermatology for Assessing Skin Cancer in 2023: Literature Review

Jones LK, Oakley A

Store-and-Forward Teledermatology for Assessing Skin Cancer in 2023: Literature Review

JMIR Dermatol 2023;6:e43395

DOI: 10.2196/43395

PMID: 37632914

PMCID: 10335330

Store-and-forward teledermatology for assessing skin cancer in 2023: A literature review

  • Leah Kirsten Jones; 
  • Amanda Oakley

ABSTRACT

Background:

The role of teledermatology for skin lesion assessment has been a recent development, particularly since the COVID-19 pandemic has impacted the ability to assess patients in person. The growing number of studies relating to this area reflects the evolving interest.

Objective:

The objective of this literature review is to analyse the available research on store-and-forward teledermatology for skin lesion assessment.

Methods:

MEDLINE was searched for articles from 2010 up to November 2021. Articles were searched for relevance to the following areas: time management, effectiveness, reception amongst patients and healthcare professionals, image quality, equity of services, education potential, fiscal measures, and medicolegal issues.

Results:

The reported effectiveness of store-and-forward teledermatology for skin lesion assessment produces heterogeneous results, likely due to large variations in procedures. Most studies show high accuracy and diagnostic concordance of teledermatology compared to in-person dermatologist assessment and histopathology. This is improved through the use of teledermoscopy. Most literature shows improvement in time to advice and definitive treatment when utilising teledermatology. The main limitation relates to incidental skin lesions which are not able to be assessed by teledermatology.

Conclusions:

Overall teledermatology offers a comparable standard of effectiveness to in-person assessment. It can save significant time in expediting advice and management. The significant number of incidental skin lesions in high-risk groups means it cannot completely substitute for an in-person assessment. The wide variation in the structure of local health systems and funding between countries and even within them means that the generalisability of teledermatology pathways described in research is difficult to predict.


 Citation

Please cite as:

Jones LK, Oakley A

Store-and-Forward Teledermatology for Assessing Skin Cancer in 2023: Literature Review

JMIR Dermatol 2023;6:e43395

DOI: 10.2196/43395

PMID: 37632914

PMCID: 10335330

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.